HealthDay - MONDAY, Sept. 28 (HealthDay News) -- Patients who take the diabetes drugs known as thiazolidinediones may be at higher risk of bone fracture, new research suggests.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.